Altered p27Kip1 phosphorylation, localization, and function in human epithelial cells resistant to transforming growth factor β-mediated G1 arrest

Molecular and Cellular Biology

Volumn 22, Issue 9, 2002, Pages 2993-3002

  Ciarallo, Sandra ^a   Subramaniam, Venkateswaran ^a   Hung, Wesley ^a   Lee, Jin Hwa ^a   Kotchetkov, Rouslan ^a   Sandhu, Charanjit ^a   Milic, Andrea ^a   Slingerland, Joyce M ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN E; PROTEIN P27; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL CYCLE G1 PHASE; CELL LINE; CELL NUCLEUS; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; EPITHELIUM CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

CELL CYCLE PROTEINS; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P27; EPITHELIAL CELLS; FLOW CYTOMETRY; G1 PHASE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOELECTRIC FOCUSING; MACROMOLECULAR SUBSTANCES; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; TEMPERATURE; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0036238894     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.9.2993-3002.2002     Document Type: Article

References (55)

1. KIP1
2. Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells
3. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
4. Decreased levels of the cellcycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer
5. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts
6. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1)
7. Transforming growth factor-beta and breast cancer: Cell cycle arrest by transforming growth factor-beta and its disruption in cancer
8. Constitutive MEK/MAPK activation leads to p27Kip1 deregulation and antiestrogen resistance in human breast cancer cells
9. Cdc25 protein phosphatases in cell proliferation
10. 1-S phase protein kinase
11. Transforming growth factor-beta and breast cancer tumor promoting effects of transforming growth factor-beta
12. TGF-beta mediated G1 arrest in a human melanoma cell line lacking p151NK4B: Evidence for cooperation between p21Cip1/WAF1 and p27Kip1
13. p151NK4B is a potential effector of TGF-beta-induced cell cycle arrest
14. A cell cycle-regulated inhibitor of cyclin-dependent kinases
15. Translational control of p27Kip1 accumulation during the cell cycle
16. Effects of transforming growth factor beta on growth of human mammary epithelial cells in culture
17. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15
18. Phosphorylation at Serine 10, a major phosphorylation site of p27Kip1, increases its protein stability
19. Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway
20. 1 in mammalian cells: Inhibition of cyclin E-dependent kinase by TGF-beta
21. New functional activities for the p21 family of CDK inhibitors
22. Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation
23. Kip1-Cdk2 complex formation: Receptor overexpression does not determine growth dependency
24. Cyclin E2: A novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle
25. Controlling TGF-beta signaling
26. D-type cyclin-dependent kinase activity in mammalian cells
27. Two-way trafficking with Ran
28. Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest
29. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation
30. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors
31. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells
32. Role of the ubiquitinproteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
33. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest
34. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta
35. INK4b·cdk4 complexes, and inhibits cyclin D1/cdk4 association in human mammary epithelial cells
36. Cyclin E-CDK2 is a regulator of p27Kip1
37. G1 phase progression: Cycling on cue
38. Inhibitors of mammalian G1 cyclindependent kinases
39. CDK inhibitors: Positive and negative regulators of G1-phase progression
40. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma
41. A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor β-arrested epithelial cells
42. Regulation of CDKs by phosphorylation
43. Formation of p27-CDK complexes during the human mitotic cell cycle
44. Isolation and growth of human mammary epithelial cells
45. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene
46. Gradual phenotypic conversion associated with immortalization of cultured human mammary epithelial cells
47. Blockage of EGF receptor signal transduction causes reversible arrest of normal and immortal human mammary epithelial cells with synchronous re-entry into the cell cycle
48. TGF beta induction of extracellular matrix associated proteins in normal and transformed human mammary epithelial cells in culture is independent of growth effects
49. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells
50. kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts
51. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jabl
52. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr 187 in p27
53. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc
54. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27
55. 1 arrest pathway